Intelligent Bio Solutions (INBS) Shareholder's Equity (QoQ) (2020 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Intelligent Bio Solutions | 13.61 Mn | 12.40 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | -39.40% |
| Mar 31, 2025 | 17.61% |
| Dec 31, 2024 | -29.35% |
| Sep 30, 2024 | -27.30% |
| Jun 30, 2024 | -25.59% |
| Mar 31, 2024 | 248.67% |
| Dec 31, 2023 | 155.08% |
| Sep 30, 2023 | -66.46% |
| Jun 30, 2023 | -37.79% |
| Mar 31, 2023 | -42.25% |
| Dec 31, 2022 | 97.51% |
| Sep 30, 2022 | -20.62% |
| Jun 30, 2022 | -24.79% |
| Mar 31, 2022 | -13.35% |
| Dec 31, 2021 | -25.60% |
| Sep 30, 2021 | -10.03% |
| Jun 30, 2021 | -5.47% |
| Mar 31, 2021 | -15.48% |
| Dec 31, 2020 | 716.30% |
| Sep 30, 2020 | 41.56% |
| Jun 30, 2020 | 11.38% |
| Mar 31, 2020 | -0.17% |